2020
DOI: 10.1080/09546634.2019.1687815
|View full text |Cite
|
Sign up to set email alerts
|

Predicting incomplete basal cell carcinoma excisions – a large multidisciplinary retrospective analysis in a tertiary center

Abstract: INTRODUCTION Surgical treatment of basal cell carcinomas is often performed by physicians with different surgical backgrounds. Collecting data from different surgical departments would better reflect their real-life surgical management. OBJETIVES To identify the rate, recurrence risk and predictive factors accordingly to their relative contribution for an incomplete basal cell carcinoma excision in a large multidisciplinary real-life setting METHODS Retrospective cohort study of 2305 surgically treated lesions… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…In other studies that have specified IERs for aggressive subtypes, the rates were 9.5–50.0% ( 11 17 , 19 22 , 24 , 27 , 28 ). Eight of these studies included <200 lesions ( 14 , 15 , 19 22 , 24 , 27 ), 4 included an unknown number of lesions ( 13 , 17 , 18 , 28 ), 1 included 275 lesions ( 11 ) and the largest study by Kappelin et al ( 12 ) included 773 lesions. In the current study, the IER was 20.6% for all high-risk tumours: 27.3% for type III and 17.6% for type II.…”
Section: Discussionmentioning
confidence: 91%
“…In other studies that have specified IERs for aggressive subtypes, the rates were 9.5–50.0% ( 11 17 , 19 22 , 24 , 27 , 28 ). Eight of these studies included <200 lesions ( 14 , 15 , 19 22 , 24 , 27 ), 4 included an unknown number of lesions ( 13 , 17 , 18 , 28 ), 1 included 275 lesions ( 11 ) and the largest study by Kappelin et al ( 12 ) included 773 lesions. In the current study, the IER was 20.6% for all high-risk tumours: 27.3% for type III and 17.6% for type II.…”
Section: Discussionmentioning
confidence: 91%